Light-chain multiple myeloma in a cat
|
|
|
- Maurice Kelley
- 9 years ago
- Views:
Transcription
1 Brief Communications 443 J Vet Diagn Invest 19: (2007) Light-chain multiple myeloma in a cat Osamu Yamada, Kyoichi Tamura, Hiroko Yagihara, Mayu Isotani, Mari Azakami, Satoko Sawada, Kenichiro Ono, Tsukimi Washizu, Makoto Bonkobara 1 Abstract. A diagnosis of light-chain multiple myeloma was made in an 11-year-old male American Shorthair cat. The cat showed atypical plasma cell infiltration in the bone marrow, biclonal gammopathy caused by polymerization of myeloma protein (M-protein), and Bence-Jones proteinuria. The M-protein in the serum of the cat was analyzed by using 12% sodium dodeyl sulfate (SDS) polyacrylamide gel electrophoresis with Coomassie brilliant blue staining. An intense band with a size of 27 kda, the size of the immunoglobulin light chain, was clearly observed, whereas the band corresponding to the immunoglobulin heavy chain (59 kda) was undetectable. The 27-kDa band was confirmed to be an immunoglobulin light chain by Western blotting by using antibodies for feline immunoglobulin. These data suggested that the neoplastic plasma cells produce light chain only, leading to the diagnosis of light-chain multiple myeloma in the cat. Key words: Bence-Jones protein; biclonal gammopathy; cats; immunoglobulin light chain; M-protein; multiple myeloma. <!?show "fnote_aff1"$^!"content-markup(./author-grp[1]/aff./author-grp[1]/dept-list)> From the Department of Veterinary Clinical Pathology (Yamada, Tamura, Yagihara, Isotani, Washizu, Bonkobara), and Veterinary Medical Teaching Hospital (Azakami, Sawada), Nippon Veterinary and Life Science University, Musashino-shi, Tokyo , and the Department of Veterinary Clinical Pathobiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo (Ono), Bunkyo-ku, Tokyo , Japan. 1 Corresponding Author: Makoto Bonkobara, Department of Veterinary Clinical Pathology, Nippon Veterinary and Life Science University, Kyonan-cho, Musashino-shi, Tokyo , Japan. [email protected] Multiple myeloma is a malignant plasma-cell dyscrasia characterized by bone-marrow plasmacytosis. Malignant plasma cells produce an abnormal monoclonal immunoglobulin; it is the most common cause of monoclonal gammopathies in humans and other animals, including dogs and cats. 4,9,12 The monoclonal immunoglobulin produced may be an entire immunoglobulin of any class, a heavy chain only, or a light chain only (light-chain multiple myeloma, also called Bence-Jones myeloma). Multiple myeloma is an uncommon neoplasm of cats and accounts for less than 1% of feline hematopoietic neoplasms. 3,7 Limited information is thus available regarding the production of immunoglobulin in feline malignant plasma cells, and myeloma producing light chain solely has not been previously reported. In this study, light-chain multiple myeloma was diagnosed in the case of a cat. An 11-year-old male American Shorthair cat was admitted to the Veterinary Medical Teaching Hospital, Nippon Veterinary and Life Science University, with anorexia, fever, and a convulsion observed the day before admission. In clinical examination, the cat was overweight (5.9 kg) and had a fever (40.0uC). On the day of presentation, complete blood cell counts (CBC), serum biochemistry, and urinalysis were performed. The CBC
2 444 Brief Communications Figure 1. Diagnostic findings of multiple myeloma in the cat. A, Cellulose acetate electrophoresis of serum protein. A sharp biclonal peak was identified in the c region. B and C, Bone marrow smear stained with Wright-Giemsa (4003 in B and 1,0003 in C). Atypical plasma-cell infiltration in the bone marrow was observed. Bars indicated in B and C are 20 mm and 5 mm, respectively. D, Western blotting analysis of the urine sample by using anti-feline IgG antibody (anti-igg) or sheep IgG (control IgG). Bence-Jones protein was clearly observed by anti-igg at the size of 27 kda. was normal, except for nonregenerative anemia (hematocrit, 23%; reference range, 30% 45%) and lymphopenia (835/ml; reference range, 1,500 7,000/ml), suggesting chronic disease and stress. In serum biochemistry, marked hyperproteinemia (12.9 g/dl; reference range, g/dl) caused by hyperglobulinemia (9.5 g/dl; reference range, g/dl) was detected. The albumin/globulin (A/G) ratio was 0.36 (reference range, ). These data suggested that the cat had monoclonal or polyclonal gammopathy. To distinguish these gammopathies, serum analysis was performed by using cellulose acetate electrophoresis. Although, unexpectedly, a sharp biclonal peak was identified in the c region (Fig. 1A), the presence of biclonal gammopathy was considered to be responsible for the hyperglobulinemia. In the serum biochemistry panel of the liver, the values of alanine aminotransferase (111 U/L; reference range, 6 83 U/L), aspartate aminotransferase (785 U/L; reference range, U/L), and alkaline phosphatase (186 U/L; reference range, U/L) were mildly to markedly increased. The serum biochemistry panel of the kidneys was normal. Serum tests for feline immunodeficiency virus and feline infectious peritonitis virus antibodies and for feline leukemia virus antigen were negative. The urinalysis of a voided urine sample showed abnormal findings, including 3+ proteinuria and a specific gravity of 1.040, considering that glomerulopathy could be present. A bone marrow aspiration biopsy was then performed on the day of presentation because of a suspicion that the cat had multiple myeloma, because of an abnormality in the serum biochemistry, including hyperproteinemia, hyperglobulinemia, decreased A/G ratio, and a clonal peak pattern of serum electrophoresis. In the light microscopic findings of a bone marrow smear stained with Wright-Giemsa, marked plasmacytosis (.50% of bone marrow cells), with anisocytosis of the plasma cells was observed in focal regions of a slide (Fig. 1B), and other regions had moderately increased numbers of the plasma cells (approximately 20% of bone marrow cells). These plasma cells had
3 Brief Communications 445 flame cell morphology, characterized by peripheral pinkstained cytoplasmic processes, and displayed atypical morphology, including anisokaryosis, variable nucleus: cytoplasm (N:C) ratios, and several binucleated cells (Fig. 1C). A urine sample was thus analyzed for the detection of Bence-Jones protein with Western blotting. Urine from the cat was diluted with phosphate-buffered saline (PBS) to the protein concentration of 150 mg/ml and boiled for 5 min in 13 SDS polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer. An aliquot was applied to 12% SDS-PAGE (300 ng protein/lane), transferred onto a polyvinylidene fluoride membrane, a and blotted with fluorescein isothiocyanate (FITC)-labeled sheep anti-feline immunoglobulin (Ig) G antibody, b which recognizes both heavy and light chains of feline IgG, or FITC-labeled sheep IgG (control). The fluorescent signal of the immunoreactive proteins was visualized by using the VersaDoc 5000 imaging system. c As shown in Fig. 1D, an immunoreactive single band was clearly observed at the size of 27 kda, which is the corresponding size of the immunoglobulin light chain, by an anti-feline IgG antibody, whereas, no band was observed with the control IgG, which indicated that the urine Bence-Jones protein was positive in the cat. No obvious multiple punctate lytic lesion was identified on survey skeletal radiographs. The cat s condition was then diagnosed as multiple myeloma based on the identification of clonal gammopathy, atypical plasma-cell infiltration in the bone marrow, and Bence- Jones proteinuria. The peak in the c region on electrophoresis analysis in multiple myeloma is typically single; however, some cases of multiple myeloma have been reported to have a biclonal peak in humans, as well as in cats. 1,5,11,15 Biclonal gammopathy is likely to occur by the polymerization of immunoglobulin, 1 a neoplastic transformation of a cell clone undergoing immunoglobulin class switching 8 or independent transforming events yielding proliferation of unrelated plasma cell clones. 16 To examine the possibility that the biclonal gammopathy is caused by the polymerization of produced immunoglobulin, serum of the case was analyzed by agarose gel electrophoresis under the nonreducing condition and the mildly reducing condition that dissociates polymerized immunoglobulin. Sera were diluted with PBS or PBS that contained 2-mercaptoethanol (2ME), a reducing agent, to a final concentration of 0.1 M. After sera were incubated at 37uC for 2 hr, 5-ml aliquots were electrophoresed on a 1% agarose gel, followed by staining with Coomassie brilliant blue (CBB) and densitometric tracing. A sharp biclonal peak was identified in the c region (right of the pattern; electrode side) under the nonreducing condition (Fig. 2; upper panel), whereas, one of the more cathode side peaks was integrated into a single peak at the more anode side peak (the side of albumin; + electrode side) under the reducing condition (Fig. 2; lower panel). Although some part of the second peak seems to be remaining as a shoulder peak in the reducing condition, it could reflect some incomplete dissociation of the multimers in the mildly reducing condition. Therefore, the biclonal peak found in this case was considered to represent the polymerization of immunoglobulin rather than the class Figure 2. Serum agarose gel electrophoresis under nonreducing and mildly reducing conditions. A sharp biclonal peak (indicated by arrowheads) was identified in the c region under the nonreducing condition (upper panel), whereas the biclonal peak was integrated into a single peak at the left under the reducing condition (lower panel). switching of immunoglobulin or the biclonal nature of plasma-cell clones. The myeloma protein (M-protein) was then analyzed by higher resolution electrophoresis. Sera from the patient and a normal cat were examined by 12% SDS-PAGE (300 ng protein/lane) followed by CBB staining (Fig. 3A). In contrast to normal cat serum, an intense band of 27 kda, the size of the immunoglobulin light chain, was clearly observed and the band corresponding to the immunoglobulin heavy chain (59 kda) was undetectable in the serum of the affected cat. These findings suggested that the
4 446 Brief Communications Figure 3. Detection of light-chain gammopathy. A, Serum protein analysis by using SDS polyacrylamide gel electrophoresis. An intense band corresponding to the immunoglobulin light chain (27 kda) was clearly detected in the serum of the affected cat, whereas it was undetectable in normal serum. The band corresponding to the immunoglobulin heavy chain (59 kda) was not detectable in affected cat serum, although it was detectable in normal serum. B, Western blotting by using anti-feline IgG antibody (anti-igg) or anti-feline immunoglobulin heavy chains (anti-igh). An intense 27-kDa band was detected in affected cat serum when compared with normal serum by anti-igg, and no detectable band was observed in the size of 59 kda by anti-igh in the affected cat serum, whereas it was detected in normal serum. malignant plasma cells produced the light chain but not the heavy chain of immunoglobulin. To confirm the 27-kDa paraprotein as an immunoglobulin light chain, Western blotting by using an antibody for feline IgG (the same antibody used for the detection of urine Bence-Jones protein) was performed after separation of serum proteins with 12% SDS-PAGE (300 ng protein/lane) (Fig. 3B; left panel). In the affected cat, an immunoreactive band of 27 kda was clearly detected that was far more intense than that in normal serum, indicating that the paraprotein in the case was a light chain of immunoglobulin. Consistent with the results of protein electrophoresis shown in Fig. 3A, no detectable band of 59 kda was observed in the affected cat serum by the same Western blotting (Fig. 3B; left panel), as well as that using feline-specific mouse monoclonal antibody for immunoglobulin heavy chain d (Fig. 3B; right panel). On the basis of these data, a diagnosis of light-chain multiple myeloma was made in the cat. The cat underwent treatment with prednisolone, but no other chemotherapy, because of deterioration of the systemic condition. The cat died 2 days after the first presentation, despite supportive therapy. Proliferation of malignant plasma cells in bone marrow might interfere with the normal production of erythrocytes, resulting in nonregenerative anemia. Elevated liver enzymes may reflect metastasis or ischemia from altered blood viscosity because of M-protein, and intense proteinuria with an increased specific gravity may indicate the presence of glomerulopathy because of light chains nephrotoxicity. These pathophysiologic abnormalities could contribute to the deterioration of systemic condition in the cat. The most common M-proteins in multiple myeloma are IgG and IgA in humans, as well as in dogs, 4,10,13 and other classes are rare. Reports of multiple myeloma that define the class of M-protein in cats have been infrequent; there are reports of IgG, IgA, and IgM, 1,6,14,17 but no previous report of light-chain multiple myeloma was found. In cases of human light-chain multiple myeloma, the detection of serum monoclonal gammopathy was relatively rare (found in 18% of patients) in spite of Bence-Jones proteinuria because of the efficient renal excretion of free light chain. 10 A case of light-chain myeloma without serum monoclonal gammopathy has been also reported in a dog. 2 In the present case, the prevention of light-chain excretion by polymerization of the chain may be associated with the existence of gammopathy in serum. Acknowledgements. This research was supported partially by a Grant-in-Aid for Scientific Research ( ) and Academic Frontier Project for Private Universities: matching fund subsidy ( ) from Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). Sources and manufacturers a. Millipore, Bedford, MA b. American Qualex, San Clemente, CA
5 Brief Communications 447 c. Bio-Rad, Richmond, CA d. Serotec, Oxford, UK References 1. Bienzle D, Silverstein DC, Chaffin K: 2000, Multiple myeloma in cats: variable presentation with different immunoglobulin isotypes in two cats. Vet Pathol 37: Cowgill ES, Neel JA, Ruslander D: 2004, Light-chain myeloma in a dog. J Vet Intern Med 18: Eastman CA: 1996, Plasma cell tumors in a cat. Feline Pract 24: Giraudel JM, Pages JP, Guelfi JF: 2002, Monoclonal gammopathies in the dog: a retrospective study of 18 cases ( ) and literature review. J Am Anim Hosp Assoc 38: Goranov S: 1994, Clinical aspects of biclonal myelomas. Folia Med (Plovdiv) 36: Hanna F: 2005, Multiple myelomas in cats. J Feline Med Surg 7: Jacobs T: 1994, Multiple myeloma in a cat with paraparesis. Feline Pract 22: Kozuru M, Uike N, Takahira H, et al.: 1997, Immunoglobulin class switch from IgA1 to IgG2 and simultaneous association with Bence Jones proteinuria in the escape phase in a myeloma patient treated with interferon alpha. Br J Haematol 98: Kyle RA: 1992, Diagnostic criteria of multiple myeloma. Hematol Oncol Clin North Am 6: Kyle RA, Gertz MA, Witzig TE, et al.: 2003, Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 78: Kyle RA, Robinson RA, Katzmann JA: 1981, The clinical aspects of biclonal gammopathies. Review of 57 cases. Am J Med 71: MacEwen EG, Hurvitz AI: 1977, Diagnosis and management of monoclonal gammopathies. Vet Clin North Am 7: Matus RE, Leifer CE, MacEwen EG, Hurvitz AI: 1986, Prognostic factors for multiple myeloma in the dog. J Am Vet Med Assoc 188: McDonald WJ, Burton SA, Fuentealba IC: 1994, Plasma cell myeloma producing an immunoglobulin A paraprotein in a cat. Can Vet J 35: Patel RT, Caceres A, French AF, McManus PM: 2005, Multiple myeloma in 16 cats: a retrospective study. Vet Clin Pathol 34: Pizzolato M, Bragantini G, Bresciani P, et al.: 1998, IgG1-kappa biclonal gammopathy associated with multiple myeloma suggests a regulatory mechanism. Br J Haematol 102: Williams DA, Goldschmidt MH: 1982, Hyperviscosity syndrome with IgM monoclonal gammopathy and hepatic plasmacytoid lymphosarcoma in a cat. J Small Anim Pract 23:
Proteins. Protein Trivia. Optimizing electrophoresis
Proteins ELECTROPHORESIS Separation of a charged particle in an electric field Michael A. Pesce, Ph.D Department of Pathology New York-Presbyterian Hospital Columbia University Medical Center Rate of migration
UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES Benjamin Parsons, DO [email protected] Gundersen Health System Center for Cancer and
UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES Benjamin Parsons, DO [email protected] Gundersen Health System Center for Cancer and Blood Disorders La Crosse, WI UNDERSTANDING MULTIPLE
Study of serum protein electrophoresis in suspected cases of Multiple Myeloma.
Journal homepage: http://www.journalijar.com INTERNATIONAL JOURNAL OF ADVANCED RESEARCH RESEARCH ARTICLE Study of serum protein electrophoresis in suspected cases of Multiple Myeloma. Dr. Dharmishtha N.
Multiple Myeloma Patient s Booklet
1E Kent Ridge Road NUHS Tower Block, Level 7 Singapore 119228 Email : [email protected] Website : www.ncis.com.sg LIKE US ON FACEBOOK www.facebook.com/ nationaluniversitycancerinstitutesingapore Multiple
Multiple Myeloma Workshop- Tandem 2014
Multiple Myeloma Workshop- Tandem 2014 1) Review of Plasma Cell Disorders Asymptomatic (smoldering) myeloma M-protein in serum at myeloma levels (>3g/dL); and/or 10% or more clonal plasma cells in bone
Monoclonal Gammopathy of Undetermined Significance (MGUS) Facts
Monoclonal Gammopathy of Undetermined Significance (MGUS) Facts Normal plasma cells (a type of white blood cell) produce antibodies (also known as immunoglobulins) which help fight infection. Each type
Understanding Serum Free Light Chain Assays
Understanding Serum Free Light Chain Assays International Myeloma Foundation 12650 Riverside Drive, Suite 206 North Hollywood, CA 91607 USA Telephone: 800-452-CURE (2873) (USA & Canada) 818-487-7455 Fax:
Meredith Maczuzak, DVM; Kenneth S. Latimer, DVM, PhD; Paula M. Krimer, DVM, DVSc; and Perry J. Bain, DVM, PhD
Canine Multiple Myeloma Meredith Maczuzak, DVM; Kenneth S. Latimer, DVM, PhD; Paula M. Krimer, DVM, DVSc; and Perry J. Bain, DVM, PhD Class of 2003 (Maczuzak) and Department of Pathology (Latimer, Krimer,
Things You Don t Want to Miss in Multiple Myeloma
Things You Don t Want to Miss in Multiple Myeloma Sreenivasa Chandana, MD, PhD Attending Hematologist and Medical Oncologist West Michigan Cancer Center Assistant Professor, Western Michigan University
Investigation of B cell malignancies. Dr. Joanna Sheldon Protein Reference Unit St. George s s Hospital
Investigation of B cell malignancies Dr. Joanna Sheldon Protein Reference Unit St. George s s Hospital The B cell progression from «Pluripotent stem cell «Lymphoid committed stem cell «B lineage committed
TABLE OF CONTENTS. Multiple Myeloma / Plasma Cell Leukemia Pre-HSCT Data
Instructions for Multiple Myeloma / Plasma Cell Leukemia Pre-HSCT Data (Form 2016) This section of the CIBMTR Forms Instruction Manual is intended to be a resource for completing the Multiple Myeloma /
chronic leukemia lymphoma myeloma differentiated 14 September 1999 Pre- Transformed Ig Surface Surface Secreted Myeloma Major malignant counterpart
Disease Usual phenotype acute leukemia precursor chronic leukemia lymphoma myeloma differentiated Pre- B-cell B-cell Transformed B-cell Plasma cell Ig Surface Surface Secreted Major malignant counterpart
1.5 Function of analyte For albumin, see separate entry. The immunoglobulins are components of the humoral arm of the immune system.
Total protein (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Total protein 1.2 Alternative names None 1.3 NMLC code 1.4 Description of analyte This is a quantitative measurement
SOUTHWEST ONCOLOGY GROUP CLINICAL RESEARCH ASSOCIATE (CRA) MANUAL. MYELOMA CHAPTER 10 REVISED: March 2008
Introduction This disease site includes the following three malignancies: multiple myeloma, amyloidosis, and waldenstrom's macroglobulinemia. See pages 4 and 5 for descriptions of the latter two diseases.
FastTest. You ve read the book... ... now test yourself
FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. Please refer back to relevant sections
MULTIPLE MYELOMA Review & Update for Primary Care. Dr. Joseph Mignone 21st Century Oncology
MULTIPLE MYELOMA Review & Update for Primary Care Dr. Joseph Mignone 21st Century Oncology OVERVIEW Identify the diagnostic criteria for multiple myeloma Compare first & second line therapies, using data
Hematology Morphology Critique
Survey Slide: History: 60-year-old female presenting with pneumonia Further Laboratory Data: Hgb : 90 g/l RBC : 2.92 10 12 /L Hct : 0.25 L/L MCV : 87 fl MCH : 30.8 pg MCHC : 355 g/l RDW : 17.7 % WBC :
Use of free light chain analysis in the diagnosis, prognosis and therapy of multiple myeloma. Amitabha Mazumder, MD
Use of free light chain analysis in the diagnosis, prognosis and therapy of multiple myeloma Amitabha Mazumder, MD Monoclonal Gammopathies Multiple Myeloma 18% Light Chain Dep Ds < 1% AL Amyloidosis 9%
Optimal Conditions for F(ab ) 2 Antibody Fragment Production from Mouse IgG2a
Optimal Conditions for F(ab ) 2 Antibody Fragment Production from Mouse IgG2a Ryan S. Stowers, 1 Jacqueline A. Callihan, 2 James D. Bryers 2 1 Department of Bioengineering, Clemson University, Clemson,
Waldenström Macroglobulinemia: The Burning Questions. IWMF Ed Forum May 18 2014 Morie Gertz MD, MACP
Waldenström Macroglobulinemia: The Burning Questions IWMF Ed Forum May 18 2014 Morie Gertz MD, MACP Are my kids going to get this? Familial seen in approximately 5 10% of all CLL patients and can be associated
Haematological Features and Serum Protein Pattern on Electrophoresis of Multiple Myeloma in Sudanese Patients
Pyrex Journal of Clinical Pathology and Forensic Medicine Vol 1 (2) pp. 009-016 November, 2015 http:///pjcpfm Copyright 2015 Pyrex Journals Original Research Article Haematological Features and Serum Protein
Plasma cell dyscrasias Mark Drayson
Plasma cell dyscrasias Mark Drayson Mortality statistics for England and Wales. Deaths attributed to multiple myeloma from 1988-1997 by age cohort as a percentage of total (21,257) deaths Deaths in age
Multiple Myeloma. The term multiple myeloma is considered to be synonymous with myeloma, plasma cell myeloma, active and symptomatic myeloma.
Multiple Myeloma. The term multiple myeloma is considered to be synonymous with myeloma, plasma cell myeloma, active and symptomatic myeloma. The intent is to positively identify patients with active or
Stem Cell Transplantation
Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance
MULTIPLE MYELOMA 1 PLASMA CELL DISORDERS Multiple l Myeloma Monoclonal Gammopathy of Undetermined Significance (MGUS) Smoldering Multiple Myeloma (SMM) Solitary Plasmacytoma Waldenstrom s Macroglobulinemia
Lyme (IgG and IgM) Antibody Confirmation
Pathology & Laboratory Medicine Lyme (IgG and IgM) Antibody Confirmation TEST UPDATE: New Test Notification Date: 1/9/2013 Effective Date: 1/7/2013 CONTACT INFO Call 802-847-5121 800-991-2799 email [email protected]
Serum Protein Electrophoresis
Serum Protein Electrophoresis Karina Rodriguez-Capote MD, PhD, FCACB, Clinical Chemist, DynaLIFE Dx 2013 Laboratory Medicine Symposium Objectives Describe the electrophoresis procedure used to separate
NON SECRETORY MULTIPLE MYELOMA A CASE REPORT
NON SECRETORY MULTIPLE MYELOMA A CASE REPORT Golwilkar A.,*Saluja R., Mehendale A. and Jalnapurkar N. Department of Histopathology, Golwilkar Metropolis Health Services (India) Pvt Ltd *Author for Correspondence
Understanding Protein Electrophoresis
Understanding Protein Electrophoresis International Myeloma Foundation 12650 Riverside Drive, Suite 206 North Hollywood, CA 91607 USA Telephone: 800-452-CURE (2873) (USA & Canada) 818-487-7455 Fax: 818-487-7454
A Clinical Primer. for Managed Care Stakeholders
reviews therapy Diagnosing, Staging, and Treating Multiple Myeloma: A Clinical Primer for Managed Care Stakeholders by Ralph V. Boccia, MD, FACP, Medical Director, Center for Cancer and Blood Disorders
Understanding Protein Electrophoresis
Understanding Protein Electrophoresis International Myeloma Foundation 12650 Riverside Drive, Suite 206 North Hollywood, CA 91607 USA Telephone: 800-452-CURE (2873) (USA & Canada) 818-487-7455 Fax: 818-487-7454
Lymphoplasmacytic Lymphoma. Hematology fellows conference 4/12/2013 Christina Fitzmaurice, MD, MPH
Lymphoplasmacytic Lymphoma versus IGM Multiple Myeloma Hematology fellows conference 4/12/2013 Christina Fitzmaurice, MD, MPH Hematology consult patient 48 yo woman presents to ER with nonspecific complaints:
I've Just Been Diagnosed. with Multiple Myeloma, What s Next?
I've Just Been Diagnosed with Multiple Myeloma, What s Next? Table of Contents Message from a Survivor Introduction What is Multiple Myeloma? What Causes Multiple Myeloma? Genes & Multiple Myeloma What
A Case of Aggressive Multiple Myeloma with Cleaved, Multilobated, and Monocytoid Nuclei, and No Serum Monoclonal Gammopathy
Annals o f Clinical & Laboratory Science, vol. 30, no. 3, 2000 283 A Case of Aggressive Multiple Myeloma with Cleaved, Multilobated, and Monocytoid Nuclei, and No Serum Monoclonal Gammopathy Y. Albert
Outline. Question 1. Question 2. What is Multiple Myeloma? Andrew Eisenberger, MD
Outline A Disease Overview June 3, 2013 Andrew Eisenberger, MD Assistant Professor of Medicine Hematology/Oncology Columbia Presbyterian Medical Center Introduction Epidemiology/Risk Factors Clinical Features/Diagnostic
Protein transfer from SDS-PAGE to nitrocellulose membrane using the Trans-Blot SD cell (Western).
Western Blot SOP Protein transfer from SDS-PAGE to nitrocellulose membrane using the Trans-Blot SD cell (Western). Date: 8/16/05, 10/31/05, 2/6/06 Author: N.Oganesyan, R. Kim Edited by: R. Kim Summary:
Extramedullary Plasmacytoma
Extramedullary Plasmacytoma Carole Fakhry MD MPH The Milton J. Dance, Jr. Head and Neck Center at GBMC HEAD AND NECK GRAND ROUNDS 9-5-2008, Baltimore, Maryland Plasmacytoma Monoclonal proliferation of
Whole Antibody and Free Light Chain Production by Plasma Cells
MYELOMA Very Good ; Stringent or Complete Navigating the maze of Responses Parameswaran Hari Medical College of Wisconsin Milwaukee Increasing understanding of disease biology in the last few years Deeper
DIAGNOSTIC SIGNIFICANCE OF SERUM PROTEIN ELECTROPHORESIS
F:/Biomedica/New Journal/Bio-2.doc (B) DIAGNOSTIC SIGNIFICANCE OF SERUM PROTEIN ELECTROPHORESIS WAQAR AZIM, SAAD AZIM, KHALID AHMED, HALEEMA SHAFI, TARIQ RAFI, M. LUQMAN Pakistan Naval Hospital Shifa,
Kharkov Regional Centre of Cardiovascular surgery V.N. Karazin Kharkov National University Department of Internal Medicine.
Kharkov Regional Centre of Cardiovascular surgery V.N. Karazin Kharkov National University Department of Internal Medicine Multiple Myeloma Associate professor Abduyeva F.M., MD, PhD 2014 Definition Multiple
Current Multiple Myeloma Treatment Adapted From the NCCN Guidelines
Current Multiple Myeloma Treatment Adapted From the NCCN Guidelines Diagnosis Survival 3-5 yrs Survival
Multiple Myeloma Making Sense of the Report Forms. Parameswaran Hari Medical College of Wisconsin Milwaukee
Hodgkin CML MDS/Other Leuk CLL Neuroblastoma Multiple Myeloma Making Sense of the Report Forms Parameswaran Hari Medical College of Wisconsin Milwaukee Indications for Blood and Marrow Transplantation
Malignant Lymphomas and Plasma Cell Myeloma
Malignant Lymphomas and Plasma Cell Myeloma Dr. Bruce F. Burns Dept. of Pathology and Lab Medicine Overview definitions - lymphoma lymphoproliferative disorder plasma cell myeloma pathogenesis - translocations
Serum protein electrophoresis is a laboratory
Understanding and Interpreting Serum Protein Electrophoresis THEODORE X. O CONNELL, M.D., TIMOTHY J. HORITA, M.D., and BARSAM KASRAVI, M.D. Kaiser Permanente Woodland Hills Family Medicine Residency Program,
Interesting Case Review. Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA
Interesting Case Review Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA History 63 y/o male with h/o CLL for 10 years Presents with worsening renal function and hypercalcemia
6/20/2014. PART I: Plasma Cell Myeloma. Plasma Cells
MULTIPLE MYELOMA: THE TESTING, VALIDATION AND IMPLEMENTATION OF CELL SEPARATION TECHNOLOGY FOR IMPROVED PATIENT CARE Elizabeth Harper CG(ASCP), Binh Vo CG(ASCP), Joey Pena CG(ASCP), Denise Lovshe CG(ASCP),
Multiple myeloma: challenges of management in a developing country
Journal of Medicine and Medical Sciences Vol. 3(6) pp. 397-403, June 2012 Available online http://www.interesjournals.org/jmms Copyright 2012 International Research Journals Full Length Research Paper
Chapter 2. S. Hovenga 1, J.Th.M. de Wolf 1, J.E.J. Guikema 4, H. Klip 2, J.W. Smit 3, C.Th. Smit Sibinga 5, N.A. Bos 4, E.
Chapter 2 Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses; a high incidence of oligoclonal serum immunoglobulins post transplantation S. Hovenga, J.Th.M. de Wolf, J.E.J.
MULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist
MULTIPLE MYELOMA Dr Malkit S Riyat MBChB, FRCPath(UK) Consultant Haematologist Multiple myeloma is an incurable malignancy that arises from postgerminal centre, somatically hypermutated B cells.
Protein electrophoresis is used to categorize globulins into the following four categories:
Globulin Globulin is one of the two types of serum proteins, the other being albumin. This generic term encompasses a heterogeneous series of families of proteins, with larger molecules and less soluble
Diagnostic accuracy of monoclonal antibody based serum immunoglobulin
1 2 Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy 3 4 Running Title: Free light chain immunoassays 5 6 Colin A Hutchison
Chapter 2 Antibodies. Contents. Introduction
Chapter 2 Antibodies Keywords Immunohistochemistry Antibody labeling Fluorescence microscopy Fluorescent immunocytochemistry Fluorescent immunohistochemistry Indirect immunocytochemistry Immunostaining
serum protein and A/ G ratio
serum protein and A/ G ratio Blood plasma contains at least 125 individual proteins. Serum ( as contrasted with plasma) is deficient in those coagulation protein which are consumed during the process of
Chapter 3 Contd. Western blotting & SDS PAGE
Chapter 3 Contd. Western blotting & SDS PAGE Western Blot Western blots allow investigators to determine the molecular weight of a protein and to measure relative amounts of the protein present in different
NATIONAL CANCER INSTITUTE. Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
NATIONAL CANCER INSTITUTE Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Basic Trial Information Phase Type Status Age Sponsor Protocol IDs Phase
STANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title: Evaluation using Western Blot SOP#: M-103 Version #: 1 Author: R. Saul Date Approved: Feb. 5, 2009 Date Modified: 1. PURPOSE The purpose of this document is to describe
Troubleshooting Guide for DNA Electrophoresis
Troubleshooting Guide for Electrophoresis. ELECTROPHORESIS Protocols and Recommendations for Electrophoresis electrophoresis problem 1 Low intensity of all or some bands 2 Smeared bands 3 Atypical banding
Fast Semi-Dry Transfer System with Yrdimes
Fast Semi-Dry Transfer System with Yrdimes INTRODUCTION Yrdimes is a semi-dry transfer system for Western blotting mainly used for fast and efficient blotting by using less transfer buffer. It is used
Pharmaceutical Biotechnology. Recombinant DNA technology Western blotting and SDS-PAGE
Pharmaceutical Biotechnology Recombinant DNA technology Western blotting and SDS-PAGE Recombinant DNA Technology Protein Synthesis Western Blot Western blots allow investigators to determine the molecular
Shaji Kumar, M.D. Multiple Myeloma: Multiple myeloma (MM) is the second most common hematological
An update on the management of multiple myeloma and amyloidosis Shaji Kumar, M.D. Multiple Myeloma: Multiple myeloma (MM) is the second most common hematological malignancy in this country affecting nearly
Protein immunoblotting
Protein immunoblotting (Western blotting) Dr. Serageldeen A. A. Sultan Lecturer of virology Dept. of Microbiology SVU, Qena, Egypt [email protected] Western blotting -It is an analytical technique used to
Utility of flow cytometric κ and λ light chain analysis of peripheral blood
JBUON 2015; 20(5): 1322-1326 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: [email protected] ORIGINAL ARTICLE Utility of flow cytometric κ and λ light chain analysis of peripheral
The immune response Antibodies Antigens Epitopes (antigenic determinants) the part of a protein antigen recognized by an antibody Haptens small
The immune response Antibodies Antigens Epitopes (antigenic determinants) the part of a protein antigen recognized by an antibody Haptens small molecules that can elicit an immune response when linked
A Rare Image. Dean M. Cestari, MD Fred Jakobiec, MD Fred Hochberg, MD Joseph F. Rizzo III, MD Rebecca C. Stacy, MD PhD
A Rare Image Dean M. Cestari, MD Fred Jakobiec, MD Fred Hochberg, MD Joseph F. Rizzo III, MD Rebecca C. Stacy, MD PhD Harvard Neuro-ophthalmology Service Boston, Massachusetts 51 year-old male financial
Information Pathway. Myeloma tests and investigations. Paraprotein measurement
Information Pathway Myeloma UK Broughton House 31 Dunedin Street Edinburgh EH7 4JG Tel: + 44 (0) 131 557 3332 Fax: + 44 (0) 131 557 9785 Myeloma Infoline 0800 980 3332 www.myeloma.org.uk Charity No. SC
Continuing Medical Education Article Imaging of Multiple Myeloma and Related Plasma Cell Dyscrasias JNM, July 2012, Volume 53, Number 7
Continuing Medical Education Article Imaging of Multiple Myeloma and Related Plasma Cell Dyscrasias JNM, July 2012, Volume 53, Number 7 Authors Ronald C. Walker 1,2, Tracy L. Brown 3, Laurie B. Jones-Jackson
Simple Method for Quantification of Bence Jones Proteins
Clinical Chemistry 48:12 2202 2207 (2002) Proteomics and Protein Markers Simple Method for Quantification of Bence Jones Proteins Morten Salomo, 1 Peter Gimsing, 1 and Lars B. Nielsen 2* Background: Quantification
Pulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic
Pulling the Plug on Cancer Cell Communication Stephen M. Ansell, MD, PhD Mayo Clinic Why do Waldenstrom s cells need to communicate? Waldenstrom s cells need activating signals to stay alive. WM cells
Reference Range: 0.5-1.6 mmol/l (arterial) 0.7-2.1 mmol/l (venous) CPT Code: 83605
LACTIC ACID Fasting, arterial specimen preferred. Please note whether arterial or venous. 0.5 ml heparinized plasma. Green top or PST must be drawn, placed on ice, and spun within 15 minutes. Immediately
Serology: Fluorescent antibody tests and other tests employing conjugated antibodies
Serology: Fluorescent antibody tests and other tests employing conjugated antibodies Authors: Adapted by Prof M van Vuuren. Originally compiled by Dr RW Worthington. (Retired) Licensed under a Creative
FURTHER EXPERIENCE WITH SUBCUTANEOUS IMMUNOGLOBULIN THERAPY IN CHILDREN WITH PRIMARY IMMUNE DEFICIENCIES
FURTHER EXPERIENCE WITH SUBCUTANEOUS IMMUNOGLOBULIN THERAPY IN CHILDREN WITH PRIMARY IMMUNE DEFICIENCIES Dr Alison Jones Great Ormond Street Hospital for Children NHS Trust London WC1N 3JH United Kingdom
LYMPHOMA IN DOGS. Diagnosis/Initial evaluation. Treatment and Prognosis
LYMPHOMA IN DOGS Lymphoma is a relatively common cancer in dogs. It is a cancer of lymphocytes (a type of white blood cell) and lymphoid tissues. Lymphoid tissue is normally present in many places in the
Clinical Aspects of Hyponatremia & Hypernatremia
Clinical Aspects of Hyponatremia & Hypernatremia Case Presentation: History 62 y/o male is admitted to the hospital with a 3 month history of excessive urination (polyuria) and excess water intake up to
Chapter 6: Antigen-Antibody Interactions
Chapter 6: Antigen-Antibody Interactions I. Strength of Ag-Ab interactions A. Antibody Affinity - strength of total noncovalent interactions between single Ag-binding site on an Ab and a single epitope
Hepatitis C. Laboratory Tests and Hepatitis C
Hepatitis C Laboratory Tests and Hepatitis C If you have hepatitis C, your doctor will use laboratory tests to check your health. This handout will help you understand what the major tests are and what
New diagnostic criteria for myeloma
New diagnostic criteria for myeloma Dr Guy Pratt Senior Lecturer/Honorary Consultant Haematologist University of Birmingham/Heart of England NHS Trust International Myeloma Working Group (IMWG) define
Effective Treatment of Lyme Borreliosis with Pentacyclic Alkaloid Uncaria tomentosa (TOA-free Cat s Claw)
Effective Treatment of Lyme Borreliosis with Pentacyclic Alkaloid Uncaria tomentosa (TOA-free Cat s Claw) Executive Summary Introduction In a six-month prospective cohort study designed to compare the
WHICH SAMPLES SHOULD BE SUBMITTED WHEN LYMPHOID NEOPLASIA IS SUSPECTED?
WHICH SAMPLES SHOULD BE SUBMITTED WHEN LYMPHOID NEOPLASIA IS SUSPECTED? Which test should be submitted? The answer to this depends on the clinical signs, and the diagnostic question you are asking. If
Comparison of Serum Beta 2-Microglobulin and 24 hour Urinary Creatinine Clearance as a Prognostic Factor in Multiple Myeloma
J Korean Med Sci 2006; 21: 639-44 ISSN 1011-8934 Copyright The Korean Academy of Medical Sciences Comparison of Serum Beta 2-Microglobulin and 24 hour Urinary Creatinine Clearance as a Prognostic Factor
HiPer Immunoelectrophoresis Teaching Kit
HiPer Immunoelectrophoresis Teaching Kit Product Code: HTI005 Number of experiments that can be performed: 5/20 Duration of Experiment: 2 days Day1- Protocol: 4 hours Day2- Observations: 15 minutes Storage
Patterns of abnormal LFTs and their differential diagnosis
Patterns of abnormal LFTs and their differential diagnosis Professor Matthew Cramp South West Liver Unit and Peninsula Schools of Medicine and Dentistry, Plymouth Summary liver function / liver function
Table of Contents Accelerate Your Research Introduction I. From the Real World to the Lab II. Research Challenges III. How Can Conversant Bio Help?
Table of Contents Accelerate Your Research 2 Introduction 3 I. From the Real World to the Lab 4 A. Diagnosing Multiple Myeloma 4 1. Lab Tests 4 2. Bone Marrow Exams 6 3. Imaging Studies 7 B. Subtypes of
International Staging System: A Tool to Predict Survival in Patients with Multiple Myeloma
World Applied Sciences Journal 16 (7): 1004-1008, 2012 ISSN 1818-4952 IDOSI Publications, 2012 International Staging System: A Tool to Predict Survival in Patients with Multiple Myeloma 1 2 3 Aneela Atta
Multiple Myeloma How to Evaluate Response To Treatment and Relapse
Multiple Myeloma How to Evaluate Response To Treatment and Relapse D R L. G AR D E R E T Saint Antoine Hospital, Paris Haematology Department 1 What is Multiple Myeloma? 4 Diagnostic Tools 8 Response to
Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.
Complete Blood Count CPT Code: CBC with Differential: 85025 CBC without Differential: 85027 Order Code: CBC with Differential: C915 Includes: White blood cell, Red blood cell, Hematocrit, Hemoglobin, MCV,
INTERPRETATION INFORMATION SHEET
Creative Testing Solutions 2424 West Erie Dr. 2205 Highway 121 10100 Martin Luther King Jr. St. No. Tempe, AZ 85282 Bedford, TX 76021 St. Petersburg, FL 33716 INTERPRETATION INFORMATION SHEET Human Immunodeficiency
Standardization and Evaluation of IgA and IgM Gel Column Agglutination for Direct Antiglobulin Testing
Standardization and Evaluation of IgA and IgM Gel Column Agglutination for Direct Antiglobulin Testing ABSTRACT BACKGROUND: Diagnosis of autoimmune hemolytic anemia is commonly confirmed with a positive
Western Blotting: Mini-gels
Western Blotting: Mini-gels Materials a Protein Extraction Buffer (for callus or kernel), Solution Stock Final Volume Tris-HCl ph 80 1 M 200 mm 20 ml NaCl 4 M 100 mm 25 ml Sucrose 2 M 400 mm 20 ml EDTA
Exercise 9: Blood. Readings: Silverthorn 5 th ed, 547 558, 804 805; 6 th ed, 545 557, 825 826.
Exercise 9: Blood Readings: Silverthorn 5 th ed, 547 558, 804 805; 6 th ed, 545 557, 825 826. Blood Typing The membranes of human red blood cells (RBCs) contain a variety of cell surface proteins called
for B cell Dyscrasias
Serum Free Light Chain Assays Recommended by International Myeloma Working Group guidelines for B cell Dyscrasias The Specialist Protein Company Index Page Introduction to Freelite 1 What is Freelite?
HuCAL Custom Monoclonal Antibodies
HuCAL Custom Monoclonal Antibodies Highly Specific Monoclonal Antibodies in just 8 Weeks PROVEN, HIGHLY SPECIFIC, HIGH AFFINITY ANTIBODIES IN 8 WEEKS WITHOUT HuCAL PLATINUM IMMUNIZATION (Human Combinatorial
Visual Acuity. Hearing. Height and Weight. Blood Pressure MEASURED VALUE
TEST ITEM DESCRIPTION STANDARD LEVEL Standard level varies among different examination methods. Please check with your medical facility about normal level. MEASURED VALUE Visual Acuity You look at rings
HuCAL Custom Monoclonal Antibodies
HuCAL Custom Monoclonal HuCAL Custom Monoclonal Antibodies Highly Specific, Recombinant Antibodies in 8 Weeks Highly Specific Monoclonal Antibodies in Just 8 Weeks HuCAL PLATINUM (Human Combinatorial Antibody
